Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects

Amino Acids

Volumn 32, Issue 2, 2007, Pages 213-224

  Fonteh, A N ^a   Harrington, R J ^a   Tsai, A ^a   Liao, P ^a   Harrington, M G ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

Alzheimer's disease; Amino acids; Cerebrospinal fluid; Dipeptides; Plasma; Tandem mass spectrometry

Indexed keywords

AMINO ACID; ANSERINE; ANTIOXIDANT; ASPARTIC ACID; CARNOSINE; CITRULLINE; DIPEPTIDE; DOPAMINE; GLUTAMIC ACID; GLYCINE; HISTIDINE; HISTIDINE DERIVATIVE; IMIDAZOLE DERIVATIVE; LEVODOPA; ORNITHINE; SERINE;

AGED; ALZHEIMER DISEASE; AMINO ACID METABOLISM; ANALYTIC METHOD; ARTICLE; BLOOD ANALYSIS; BODY FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; PRIORITY JOURNAL; PROTEIN METABOLISM; TANDEM MASS SPECTROMETRY; UREA CYCLE; URINALYSIS;

AGED; ALZHEIMER DISEASE; AMINO ACIDS; ANTIOXIDANTS; CARNOSINE; CHROMATOGRAPHY, LIQUID; DIPEPTIDES; DISEASE PROGRESSION; FEMALE; HISTIDINE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 33846680631     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-006-0409-8     Document Type: Article

References (67)

1. C Advokat AI Pellegrin 1992 Excitatory amino acids and memory: evidence from research on Alzheimer's disease and behavioral pharmacology Neurosci Biobehav Rev 16 13 24
2. Y Agid P Pollak AM Bonnet JL Signoret F Lhermitte 1979 Bromocriptine associated with a peripheral dopamine blocking agent in treatment of Parkinson's disease Lancet 1 570 572
3. 2-like receptors on peripheral blood lymphocytes in Alzheimer's disease Mech Ageing Dev 120 65 75
4. P Barili E Bronzetti L Felici F Ferrante A Ricci D Zaccheo F Amenta 1996 Age-dependent changes in the expression of dopamine receptor subtypes in human peripheral blood lymphocytes J Neuroimmunol 71 45 50
5. S Berl H Waelsch 1958 Determination of glutamic acid, glutamine, glutathione and gamma-aminobutyric acid and their distribution in brain tissue J Neurochem 3 161 169
6. AA Boldyrev SC Gallant GT Sukhich 1999 Carnosine, the protective, anti-aging peptide Biosci Rep 19 581 587
7. P Bolme K Fuxe T Hokfelt M Goldstein 1977 Studies on the role of dopamine in cardiovascular and respiratory control: central versus peripheral mechanisms Adv Biochem Psychopharmacol 16 281 290
8. L Bonfanti P Peretto S De Marchis A Fasolo 1999 Carnosine-related dipeptides in the mammalian brain Prog Neurobiol 59 333 353
9. D Bowen 1990 The cholinergic system and the excitatory amino acids in Alzheimer's disease Acta Neurol Scand [Suppl] 129 15 16
10. B Caronti G Tanda C Colosimo S Ruggieri C Calderaro G Palladini FE Pontieri G Di Chiara 1999 Reduced dopamine in peripheral blood lymphocytes in Parkinson's disease Neuroreport 10 2907 2910
11. PF Chapman AM Falinska SG Knevett MF Ramsay 2001 Genes, models and Alzheimer's disease Trends Genet 17 254 261
12. GU Corsini M Del Zompo F Tocco P Arca GL Gessa 1980 Drugs acting on dopamine receptors: usefulness of a peripheral blocker in Parkinson's disease Pharmacol Res Commun 12 699 707
13. JG Csernansky ME Bardgett YI Sheline JC Morris JW Olney 1996 CSF excitatory amino acids and severity of illness in Alzheimer's disease Neurology 46 1715 1720
14. JL Cummings DV Jeste 1999 Alzheimer's disease and its management in the year 2010 Psychiatr Serv 50 1173 1177
15. JL Cummings D Knopman 1999 Advances in the treatment of behavioral disturbances in Alzheimer's disease Neurology 53 899 901
16. JL Cummings HV Vinters GM Cole ZS Khachaturian 1998 Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities Neurology 51 S2 S17
17. G D'Andrea AR Cananzi R Joseph M Morra F Zamberlan MF Ferro S Grunfeld KM Welch 1991 Platelet glycine, glutamate and aspartate in primary headache Cephalalgia 11 197 200
18. I Date T Ohmoto 1996 Neural transplantation and trophic factors in Parkinson's disease: special reference to chromaffin cell grafting, NGF support from pretransected peripheral nerve, and encapsulated dopamine-secreting cell grafting Exp Neurol 137 333 344
19. PM Doraiswamy J Leon JL Cummings D Marin PJ Neumann 2002 Prevalence and impact of medical comorbidity in Alzheimer's disease J Gerontol A Biol Sci Med Sci 57 M173 M177
20. PF Fitzpatrick 1991 Studies of the rate-limiting step in the tyrosine hydroxylase reaction: alternate substrates, solvent isotope effects, and transition-state analogues Biochemistry 30 6386 6391
21. F Fonnum 1984 Glutamate: a neurotransmitter in mammalian brain J Neurochem 42 1 11
22. AN Fonteh JR Harrington MG Harrington 2007 Quantification of free amino acids and dipeptides using isotope dilution liquid chromatography electrospray tandem mass spectrometry Amino Acids 32 203 212
23. V Gallai A Alberti B Gallai F Coppola A Floridi P Sarchielli 2003 Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid Cephalalgia 23 166 174
24. 1 receptor modulation of gastric secretion and experimental gastric mucosal injury Gen Pharmacol 26 1277 1279
25. DS Goldstein E Mezey T Yamamoto A Aneman P Friberg G Eisenhofer 1995 Is there a third peripheral catecholaminergic system? Endogenous dopamine as an autocrine/paracrine substance derived from plasma DOPA and inactivated by conjugation Hypertens Res 18 [Suppl 1] S93 S99
26. BS Gould JF Woessner 1957 Biosynthesis of collagen; the influence of ascorbic acid on the proline, hydroxyproline, glycine, and collagen content of regenerating guinea pig skin J Biol Chem 226 289 300
27. JT Greenamyre AB Young 1989 Excitatory amino acids and Alzheimer's disease Neurobiol Aging 10 593 602
28. E Grunblatt S Mandel MB Youdim 2000 Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP Ann NY Acad Sci 899 262 273
29. AR Hipkiss 2002 Could carnosine be a naturally-occurring scavenger for acrolein and other reactive aldehydes in the brain? Neurobiol Aging 23 645 646
30. P Husek 1998 Chloroformates in gas chromatography as general purpose derivatizing agents J Chromatogr B Biomed Sci Appl 717 57 91
31. DS Knopman ST DeKosky JL Cummings H Chui J Corey-Bloom N Relkin GW Small B Miller JC Stevens 2001 Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 56 1143 1153
32. R Kohen Y Yamamoto KC Cundy BN Ames 1988 Antioxidant activity of carnosine, homocarnosine, and anserine present in muscle and brain Proc Natl Acad Sci USA 85 3175 3179
33. JD Kohli 1990 Peripheral dopamine receptors Am J Hypertens 3 25S 28S
34. JD Kohli JL McNay SI Rajfer MB Murphy 1991 Peripheral dopamine receptors in cardiovascular therapy. The legacy of Leon Goldberg (1927-1989) Hypertension 17 700 706
35. O Kuchel 1999 Peripheral dopamine in hypertension and associated conditions J Hum Hypertens 13 605 615
36. Z Lackovic M Relja NH Neff 1982 Catabolism of endogenous dopamine in peripheral tissues: is there an independent role for dopamine in peripheral neurotransmission? J Neurochem 38 1453 1458
37. WJ Lee RA Hawkins JR Vina DR Peterson 1998 Glutamine transport by the blood-brain barrier: a possible mechanism for nitrogen removal Am J Physiol 274 C1101 C1107
38. Z Liu J Zhang J Fei L Guo 2001 A novel mechanism of dopamine neurotoxicity involving the peripheral extracellular and the plasma membrane dopamine transporter Neuroreport 12 3293 3297
39. D Marazziti E Hollander P Lensi S Ravagli GB Cassano 1992 Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder Psychiatry Res 42 41 51
40. SD Marchis C Modena P Peretto A Migheli FL Margolis A Fasolo 2000 Carnosine-related dipeptides in neurons and glia Biochemistry (Mosc.) 65 824 833
41. WR Markesbery JM Carney 1999 Oxidative alterations in Alzheimer's disease Brain Pathol 9 133 146
42. A Mayerhofer HC Hemmings Jr GL Snyder P Greengard S Boddien U Berg C Brucker 1999 Functional dopamine-1 receptors and DARPP-32 are expressed in human ovary and granulosa luteal cells in vitro J Clin Endocrinol Metab 84 257 264
43. G McKhann D Drachman M Folstein R Katzman D Price EM Stadlan 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease Neurology 34 939 944
44. M Memo C Missale MO Carruba PF Spano 1986 Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue J Neural Transm [Suppl] 22 19 32
45. MS Mendiondo JW Ashford RJ Kryscio FA Schmitt 2000 Modelling mini mental state examination changes in Alzheimer's disease Stat Med 19 1607 1616
46. JA Molina FJ Jimenez-Jimenez C Vargas P Gomez F de Bustos M Orti-Pareja A Tallon-Barranco J Benito-Leon J Arenas R Enriquez-de-Salamanca 1998 Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease J Neural Transm 105 279 286
47. MB Murphy C Murray GD Shorten 2001 Fenoldopam: a selective peripheral dopamine-receptor agonist for the treatment of severe hypertension N Engl J Med 345 1548 1557
48. M Nedergaard T Takano AJ Hansen 2002 Beyond the role of glutamate as a neurotransmitter Nat Rev Neurosci 3 748 755
49. TL Perry VW Yong C Bergeron S Hansen K Jones 1987 Amino acids, glutathione, and glutathione transferase activity in the brains of patients with Alzheimer's disease Ann Neurol 21 331 336
50. N Pomara R Singh D Deptula JC Chou MB Schwartz PA LeWitt 1992 Glutamate and other CSF amino acids in Alzheimer's disease Am J Psychiatry 149 251 254
51. JE Preston AR Hipkiss DT Himsworth IA Romero JN Abbott 1998 Toxic effects of beta-amyloid(25-35) on immortalised rat brain endothelial cell: protection by carnosine, homocarnosine and beta-alanine Neurosci Lett 242 105 108
52. R Sandbrink T Hartmann CL Masters K Beyreuther 1996 Genes contributing to Alzheimer's disease Mol Psychiatry 1 27 40
53. P Schofield 1996 Glycine: the other inhibitory neurotransmitter Alcohol Clin Exp Res 20 219A 223A
54. AN Singh C Barlas H Saeedi RK Mishra 2003 Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia J Psychiatry Neurosci 28 39 47
55. SR Snider 1975 Letter: Release of peripheral dopamine during stress Lancet 2 868
56. D Storga K Vrecko JG Birkmayer G Reibnegger 1996 Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients Neurosci Lett 203 29 32
57. HJ Stuerenburg 2000 The roles of carnosine in aging of skeletal muscle and in neuromuscular diseases Biochemistry (Mosc.) 65 862 865
58. SL Stvolinskii TN Fedorova MO Yuneva AA Boldyrev 2003 Protective effect of carnosine on Cu, Zn-superoxide dismutase during impaired oxidative metabolism in the brain in vivo Bull Exp Biol Med 135 130 132
59. WH Vogel SD Heginbothom DH Boehme 1975 Glutamic acid decarboxylase, glutamine synthase and glutamic acid dehydrogenase in various areas of human brain Brain Res 88 131 135
60. FA Walker 2004 Models of the bis-histidine-ligated electron-transferring cytochromes. Comparative geometric and electronic structure of low-spin ferro- and ferrihemes Chem Rev 104 589 615
61. D Wang JB Chalk SE Rose G de Zubicaray G Cowin GJ Galloway D Barnes D Spooner DM Doddrell J Semple 2002 MR image-based measurement of rates of change in volumes of brain structures. Part II: application to a study of Alzheimer's disease and normal aging Magn Reson Imaging 20 41 48
62. RJ Weinberg 1999 Glutamate: an excitatory neurotransmitter in the mammalian CNS Brain Res Bull 50 353 354
63. G Weyer H Erzigkeit S Kanowski R Ihl D Hadler 1997 Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial Int Psychogeriatr 9 123 138
64. NM White MG Packard J Seamans 1993 Memory enhancement by post-training peripheral administration of low doses of dopamine agonists: possible autoreceptor effect Behav Neural Biol 59 230 241
65. S Yoneda H Tomioka M Fukuyama LC Lee I Iyota H Okajima A Inoue S Sasaki K Takeda H Takahashi 1985 Peripheral origin of plasma dopamine Jpn Circ J 49 1028 1034
66. J Zhang V Kravtsov V Amarnath MJ Picklo DG Graham TJ Montine 2000 Enhancement of dopaminergic neurotoxicity by the mercapturate of dopamine: relevance to Parkinson's disease J Neurochem 74 970 978
67. SS Zuo P Lundahl 2000 A micro-Bradford membrane protein assay Anal Biochem 284 162 164